ChemoMetec ASFRA:CHY -0.49%99 Operating Margin % is 48.42% as of Dec. 2025, which is 25% above its 10-year median of 38.74. GuruFocus rates FRA:CHY with a GF Score™ of 99/100 and a GF Value™ of €69.05 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 816 Medical Devices & Instruments companies, ChemoMetec AS ranks better than 98.9% on this metric.
ChemoMetec AS operating margin is expanding. Margin expansion is usually a good sign.
The historical rank and industry rank for ChemoMetec AS's Operating Margin % or its related term are showing as below:
FRA:CHY'
s Operating Margin % Range Over the Past 10 Years
Min: 11.28 Med: 38.74 Max: 51.9
Current: 46.86
FRA:CHY's Operating Margin % is ranked better than 98.9% of 816
companies
in the Medical Devices & Instruments industry
Industry Median: 3.465
vs FRA:CHY: 46.86
ChemoMetec AS's 5-Year Average Operating Margin % Growth Rate was 4.30% per year.
ChemoMetec AS (FRA:CHY) Operating Margin % Explanation
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
ChemoMetec AS Operating Margin % Related Terms
ChemoMetec AS Operating Margin % Historical Data
* Premium members only.
The historical data trend for ChemoMetec AS's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:CHY vs ABT, SYK, MDT: Operating Margin % Comparison
For the Medical Devices subindustry, ChemoMetec AS's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ChemoMetec AS Operating Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, ChemoMetec AS's Operating Margin % distribution charts can be found below:
* The bar in red indicates where ChemoMetec AS's Operating Margin % falls into.
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
ChemoMetec AS's Operating Margin % for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ChemoMetec AS (FRA:CHY) has a Operating Margin % of 48.42% as of Dec. 2025. Operating margin is the ratio of total operating income to net sales. View historical data on ChemoMetec AS and its competitors. This is 25% above median its historical median of 38.74. Over the past decade, ChemoMetec AS's Operating Margin % has ranged from 11.28 to 51.90. According to the industry distribution chart, ChemoMetec AS ranks #9 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 1.1%.
Is ChemoMetec AS's Operating Margin % too high?
ChemoMetec AS's current Operating Margin % of 48.42% is 25% above median its 10-year median of 38.74. Over the past 10 years, this metric has ranged from a low of 11.28 to a high of 51.90. The Medical Devices & Instruments industry median Operating Margin % is 3.47. ChemoMetec AS's value of 48.42% is 1297.4% above this industry median. Based on the distribution chart, ChemoMetec AS ranks #9 out of 816 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, ChemoMetec AS has a GF Score™ of 99/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ChemoMetec AS's Operating Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, ChemoMetec AS ranks #9 out of 816 companies for Operating Margin %. This places ChemoMetec AS in the top 1% of its industry — outperforming the majority of peers. The industry median Operating Margin % is 3.47. ChemoMetec AS's value of 48.42% is 1297.4% above this benchmark. Historically, ChemoMetec AS's own Operating Margin % has ranged from 11.28 to 51.90 over the past decade. While the company's 10-year median is 38.74 vs. the industry median of 3.47, ChemoMetec AS has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Medical Devices & Instruments company?
The median Operating Margin % among Medical Devices & Instruments companies is 3.47, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ChemoMetec AS's current Operating Margin % of 48.42% is 1297.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on ChemoMetec AS and its competitors. For the Medical Devices & Instruments industry, the median Operating Margin % is 3.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ChemoMetec AS's current Operating Margin % is 48.42%, which is 25% above median its own 10-year median of 38.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ChemoMetec AS stock overvalued right now?
Based on GuruFocus' analysis, ChemoMetec AS (FRA:CHY) is currently considered Modestly Undervalued. The stock's GF Value™ is €69.05, compared to a current price of €48.74 — trading 29.4% below its estimated fair value. The current Operating Margin % is 48.42%, which is 25% above median its 10-year median of 38.74 and 1297.4% above the Medical Devices & Instruments industry median of 3.47. ChemoMetec AS's overall GF Score™ is 99/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For ChemoMetec AS (FRA:CHY), the current Operating Margin % is 48.42% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ChemoMetec AS (FRA:CHY) Overvalued in 2026?
Based on GuruFocus' analysis, ChemoMetec AS stock appears to be undervalued.
The current stock price of €48.74 is trading 29.4% below its estimated GF Value™ of €69.05.
GuruFocus considers ChemoMetec AS to be Modestly Undervalued.
Key valuation signals for FRA:CHY:
Operating Margin %: 48.42% (25% above median its 10-year median of 38.74)
GF Value™: €69.05 vs. price of €48.74 (29.4% below fair value)
Industry Position: 1297.4% above the Medical Devices & Instruments median (#9 of 816)
No single metric tells the full story. See the FRA:CHY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ChemoMetec AS specializes in designing, developing, and producing instruments using patented technology in cell counting and evaluation. It is engaged in the manufacturing and marketing of analytical instruments used for quantitative analysis of cells in liquids. Its applications include Cell Analysis and counting of Mammalian Cells, Yeast Cells, and Sperm Cells. It provides platforms for the determination of viability and cell count of yeast, veterinary semen, mammalian cells, and somatic cells as well as image analysis. It has four segments instruments; consumables; services and others, and the majority of its revenue is generated from the Consumable segment.
99GF Score
Get the complete analysis for FRA:CHY
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:CHY has been successfully added to your 
